Enze Kangtai: Funding, Investors & Team (Sep 2026)
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.
Enze Kangtai has raised $14.0M across 1 funding round on record, the most recent a Series B of $14.0M announced in Nov 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Enze Kangtai Company Profile and Key Stats
Latest funding round on record: Nov 2025.
Enze Kangtai Funding Rounds
Enze Kangtai Funding Compared to Other Biotechnology Startups
Enze Kangtai's latest round of $14.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Enze Kangtai in Biotechnology and Changping
Companies Similar to Enze Kangtai
Protoga is a biotech firm that focused on the development of innovative microalgae biosynthesis technology.
Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET…
NewLine researches phage feed additives to prevent livestock infections.
Salus BioMed is an innovative biomedical company that specializes in developing genetic sequencing technology…
Epigenic Therapeutics is a drug development company that develops gene modulation therapies through the…
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of…
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The…
JW Therapeutics is a developer of cell-based therapy technologies created to revolutionize cancer…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Enze Kangtai Funding FAQs
What does Enze Kangtai do?
Echo Biotech is a biotech firm mainly engaged in the R&D and production of exosome molecular diagnostic products and exosome research.
How much funding has Enze Kangtai raised?
Enze Kangtai has raised $14.0M across 1 round on record. The most recent is a Series B of $14.0M announced in Nov 2025.
When did Enze Kangtai last raise funding?
Enze Kangtai's most recent funding round on record is a Series B of $14.0M, announced in Nov 2025.
Where is Enze Kangtai headquartered?
Enze Kangtai is based in Changping, China.
How many employees does Enze Kangtai have?
Enze Kangtai is in the 101-250 employee band.
How does Enze Kangtai's funding compare to other Biotechnology startups?
Enze Kangtai's latest round of $14.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Enze Kangtai Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Enze Kangtai is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.